Deletion variant of hepatocyte growth factor prolongs allograft survival after liver transplantation in rats

Surgery

Volumn 125, Issue 6, 1999, Pages 602-607

  Ikegami, Toru ^a   Nishizaki, Takashi ^a   Uchiyama, Hideaki ^a   Kakizoe, Saburo ^a   Yanaga, Katsuhiko ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLINE; SCATTER FACTOR; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032994373     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70223-0     Document Type: Article

References (24)

1. 1. Klintmalm GB. Rejection therapies. Dig Dis Sci 1991; 30:1431-3.
2. 2. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988;67:132-43.
3. 3. Berlakovich GA, Rockenschaub S, Taucher S, Kaserer K, Muhlbacher F, Steiniger R, et al. Underlying disease as a predictor for rejection after liver transplantation. Arch Surg 1998;133:167-72.
4. 4. Bottaro DP, Rubin JS, Faletto DL, Chan A, Kmiecik TE, Vandw Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-4.
5. 5. Hu Z, Evarts RP, Fujio K, Marsden ER, Thorgeirsson SS. Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat. Am J Pathol 1993;142:1823-30.
6. 6. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-6.
7. 7. Nishizaki T, Takenaka K, Yanaga K, Shirabe K, Itasaka H, Yamamoto K, et al. Elevation of hepatocyte growth factor levels in portal and hepatic veins immediately after hepatic resection in cirrhotic patients. Am J Gastroenterol 1995;90:331-2.
8. 8. Morita M, Watanabe Y, Akaike T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 1995;21:1585-93.
9. 9. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent anti-hepatitis effect in vivo. Hepatology 1992;16:1227-35.
10. 10. Shima N, Tsuda E, Goto M, Yano K, Hayasaka H, Ueda M, et al. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Biochem Biophys Res Commun 1994;200:808-15.
11. 11. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28:47-50.
12. 12. Masunaga H, Fujise N, Shiota A, Yamashita Y, Yasuda H, Higashio K. Amelioration of disordered hepatic protein synthesis by the deleted form of hepatocyte growth factor in models of liver failure in rats. J Pharm Pharmacol 1996;48:876-9.
13. 13. Masunaga H, Fujise N, Yamashita Y, Shiota A, Yasuda H, Higashio K. Deleted form of hepatocyte growth factor (dHGF) increases the number of platelets in rats with liver cirrhosis. Liver 1907;17:192-7.
14. 14. Matsumoto T, Komori K, Yonemitsu Y, Morishita R, Sueishi K, Kaneda Y, et al. Hemagglutinating virus of Japan-liposome-medicated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff. J Vasc Surg 1998;27:135-44.
15. 15. Li XK, Kita Y, Tamura A, Enosawa S, Amemiya H, Suzuki S. Activation of Fas and perforin pathways in rat liver allograft rejection. Transplant Proc 1998;30:19-21.
16. 16. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997;26:81-9.
17. 17. Okano J, Shiota G, Kawasaki H. Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Hepatology 1997;26:1241-9.
18. 18. Adams DH, Harvath L, Bottaro DP, Interrante R, Catalano G, Tanaka Y, et al. Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid Cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Sci U S A 1994;91:7144-8
19. 19. Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia-Kennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995;59:621-5.
20. 20. Hayashi A, Ito H, Shomori K, Ohdan H, Yano K, Asahara T. Frequent occurrence of hepatocytic apoptosis in acute rejection of the grafted rat liver. Pathol Int 1997;47:518-24.
21. 21. Qian S, Lu L, Fu F, Li Y, Li W, Starzl TE, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997; 158:4054-61.
22. 22. Shinagawa T, Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, et al. Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor alpha and interferon gamma. J Pathol 1991;165:247-53.
23. 23. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A 1992;89: 5408-12.
24. 24. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998;244:683-90.